Important Information for Patients.
Sevoflurane Baxter contains sevoflurane. Sevoflurane is a general anesthetic used in surgery for adults and children. It is an inhalational anesthetic (given by inhaling vapor) that induces deep sleep without feeling pain and maintains deep sleep without feeling pain (general anesthesia) during which surgery can be performed. If there is no improvement or the patient feels worse, they should consult a doctor.
Sevoflurane should only be administered by qualified medical personnel, properly trained in the administration of general anesthesia, under the supervision of an anesthesiologist or by an anesthesiologist.
If any of the above points apply, the anesthesiologist (doctor) should be informed before administering the medicine.
Before starting treatment with Sevoflurane Baxter, you should consult your doctor or pharmacist if:
Children
If any of the above points apply, you should confirm this with your doctor, nurse, or pharmacist. The patient may require thorough examinations, and treatment may be changed.
You should tell your doctor, pharmacist, surgeon, or anesthesiologist about all medicines you are currently taking or have recently taken, as well as any medicines you plan to take. This also applies to herbal medicines and vitamins and minerals. The following medicines or active substances contained in these medicines may interact with the effects of Sevoflurane Baxter when used concurrently. Some of these medicines are administered during surgery by the anesthesiologist, as described.
Sevoflurane Baxter is a medicine that induces and maintains sleep to allow surgery to be performed. You should ask your doctor, surgeon, or anesthesiologist when and what the patient will be able to eat or drink after waking up from anesthesia.
If the patient is pregnant or breastfeeding, if she suspects she is pregnant, or plans to become pregnant, she should consult her doctor, surgeon, or anesthesiologist before using the medicine.
Sevoflurane Baxter has a strong effect on the ability to drive vehicles and use tools. You should not drive vehicles, use tools, or operate any mechanical equipment until your doctor considers it safe. Receiving an anesthetic may affect your perception for several days. It may also affect your ability to perform tasks that require intellectual performance. You should ask your anesthesiologist when you can safely drive vehicles and operate mechanical equipment again.
Sevoflurane Baxter will be administered by an anesthesiologist. The anesthesiologist will determine the appropriate dose and duration of administration for the patient. The dose will vary depending on the patient's age, weight, type of surgical procedure, and other medicines administered during surgery. Sevoflurane Baxter is produced from liquid sevoflurane in a device called a vaporizer, specifically designed for use with sevoflurane. Induction of anesthesia may be performed by inhaling sevoflurane vapor through a mask. The patient may also receive an injection of another anesthetic that will induce sleep before using Sevoflurane Baxter, administered through a mask or a tube in the throat. The anesthesiologist will decide when to stop administering Sevoflurane Baxter. Recovery occurs within a few minutes.
Sevoflurane Baxter will be administered by qualified medical personnel, and it is unlikely that the patient will receive too much Sevoflurane Baxter. If the patient receives too much Sevoflurane Baxter, the anesthesiologist will take all necessary measures.
Like all medicines, this medicine can cause side effects, although not everybody gets them. Most side effects are mild to moderate and short-lived, but severe side effects can also occur. Severe Side Effects(can be life-threatening)
If these symptoms occur during administration of Sevoflurane Baxter, the anesthesiologist will take appropriate action.
Sometimes, seizure-like attacks have been observed. They can occur during administration of Sevoflurane Baxter or up to one day after anesthesia. They mainly occur in children and young adults. In children with Down syndrome who receive sevoflurane, bradycardia (slow heart rate) may occur. During or immediately after anesthesia, fluoride levels in the blood may be slightly elevated, but they are not considered harmful and quickly return to normal. If any of the side effects worsen or if you experience any side effects not listed in this leaflet, you should inform your doctor or pharmacist. If you notice any change in your condition after using sevoflurane, you should inform your doctor or pharmacist. Some side effects may require treatment.
If you experience any side effects, including those not listed in this leaflet, you should inform your doctor, surgeon, or nurse. Side effects can be reported directly to the Department of Adverse Reaction Monitoring of Medicinal Products, Medical Devices, and Biocidal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, Tel.: +48 22 49 21 301, Fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl. Side effects can also be reported to the marketing authorization holder. By reporting side effects, you can help provide more information on the safety of this medicine.
The medicine should be stored out of sight and reach of children. Do not use Sevoflurane Baxter after the expiry date stated on the label. The expiry date refers to the last day of the month. There are no special precautions for storage.
The active substance of the medicine is sevoflurane 100% (250 ml in a 250 ml bottle). The product does not contain any other ingredients.
Sevoflurane is a clear, colorless liquid for inhalation vapor. It is supplied in 250 ml aluminum bottles with an internal protective coating. The bottle may be closed with a plastic cap or an integrated valve that connects directly to a suitable vaporizer. Package sizes: 1 or 6 bottles. Not all pack sizes may be marketed.
MARKETING AUTHORIZATION HOLDER
Baxter Polska Sp. z o.o.
ul. Kruczkowskiego 8
00-380 Warsaw
tel. 22 488 37 77
MANUFACTURER
Baxter SA
Boulevard Rene Branquart 80,
B-7860 Lessines, Belgium
Member State | Name |
Austria | Sevofluran "Baxter" Flüssigkeit zur Herstellung eines Dampfs zur Inhalation |
Belgium | Sevoflurane Baxter 100%, liquide pour inhalation par vapeur |
Bulgaria | Sevoflurane Baxter 100% |
Czech Republic | Sevoflurane Baxter |
Denmark | Sevofluran "Baxter" |
Estonia | Sevoflurane Baxter 100% |
Finland | Sevoflurane Baxter 100%, inhalaatiohöyry, neste |
France | Sevoflurane Baxter 1 ml/ml, Liquide pour Inhalation par Vapeur |
Germany | Sevofluran Baxter Flüssigkeit zur Herstellung eines Dampfs zur Inhalation |
Hungary | Sevoflurane Baxter, folyadék inhalációs gőz képzéséhez |
Iceland | Sevofluran Baxter 100% innöndunargufa, vökvi |
Ireland | Sevoflurane Baxter, 100%, inhalation vapour, liquid |
Italy | Sevoflurane Baxter 100% Liquido per inalazione |
Latvia | Sevoflurane Baxter 100% inhalācijas tvaiki, šķidrums |
Lithuania | Sevoflurane Baxter 100% inhaliaciniai garai, skystis |
Netherlands | Sevoflurane Baxter, vloeistof voor inhalatiedamp 100% |
Norway | Sevofluran Baxter Væske Til Inhalasjonsdamp 100% “Baxter” |
Poland | Sevoflurane Baxter, 100%, płyn do sporządzania inhalacji parowej |
Portugal | Sevoflurano Baxter |
Romania | Sevofluran Baxter 100% lichid pentru vapori de inhalat |
Slovakia | Sevoflurane Baxter |
Slovenia | Sevofluran Baxter 250 ml para za inhaliranje, tekočina |
Spain | Sevoflurano 100% Baxter, Líquido para inhalación del vapor |
Sweden | Sevofluran Baxter, 100% inhalationsånga, vätska |
United Kingdom (Northern Ireland) | Sevoflurane Baxter 100% Inhalation Vapour, Liquid |
Baxter is a trademark of Baxter International Inc.
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.